Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. www.icd10data.com › ICD10CM › Codes2025 ICD-10-CM Codes Z12*: Encounter for screening for malignant...

   www.icd10data.com › ICD10CM › Codes

   • Αποθηκευμένο αντίγραφο

   Applicable To. Screening is the testing for disease or disease precursors in asymptomatic individuals so that early detection and treatment can be provided for those who test positive for the disease. Use Additional. code to identify any family history of malignant neoplasm (Z80.-) Type 1 Excludes.

2. www.frontiersin.org › journals › molecular-biosciencesMolecular Diagnostics in Clinical Oncology - Frontiers

   www.frontiersin.org › journals › molecular-biosciences

   • Αποθηκευμένο αντίγραφο

   26 Αυγ 2018 · Personalized selection of cancer drugs based on the presence of actionable mutations has become an integral part of cancer therapy. Molecular tests underlie the administration of EGFR, BRAF, ALK, ROS1, PARP inhibitors as well as the use of some other cytotoxic and targeted drugs.

3. link.springer.com › chapter › 10Molecular Diagnostics in Cancer: A Fundamental Component of ... -...

   link.springer.com › chapter › 10

   • Αποθηκευμένο αντίγραφο

   2 Ιαν 2020 · In contrast to the molecular diagnostics of hereditary diseases, which relate largely to disease diagnosis, a major focus of cancer molecular diagnostics is on its predictive value for guiding the selection of therapies.

4. jcp.bmj.com › content › 67/11/923Reporting molecular pathology tests for cancer patients

   jcp.bmj.com › content › 67/11/923

   • Αποθηκευμένο αντίγραφο

   Molecular testing is becoming an important part of the diagnosis of any patient with cancer.

5. www.cms.gov › medicare-coverage-database › viewBilling and Coding: MolDX: Minimal Residual Disease Testing for...

   www.cms.gov › medicare-coverage-database › view

   • Αποθηκευμένο αντίγραφο

   26 Δεκ 2021 · The following ICD-10 codes can be used with MRD tests for the purpose of diagnosing disease progression, recurrence, or relapse. Group 1 Codes

6. pubmed.ncbi.nlm.nih.gov › 25012948Guidance for laboratories performing molecular pathology for...

   pubmed.ncbi.nlm.nih.gov › 25012948

   Molecular testing is becoming an important part of the diagnosis of any patient with cancer. The challenge to laboratories is to meet this need, using reliable methods and processes to ensure that patients receive a timely and accurate report on which their treatment will be based.